121 related articles for article (PubMed ID: 8227414)
1. Nucleolar organiser regions and survival in patients with non-Hodgkin's lymphomas classified by the working formulation.
Jakić-Razumović J; Tentor D; Petrovecki M; Radman I
J Clin Pathol; 1993 Oct; 46(10):943-7. PubMed ID: 8227414
[TBL] [Abstract][Full Text] [Related]
2. AgNORs predictive value of prognosis in non-Hodgkin's lymphoma according to the Kiel classification.
Jakić-Razumović J; Petrovecki M; Dominis M
Mod Pathol; 1995 Feb; 8(2):143-9. PubMed ID: 7777474
[TBL] [Abstract][Full Text] [Related]
3. AgNORs predictive value of prognosis in non-Hodgkin's lymphoma: comparison with flow cytometric cell cycle analysis.
Jakić-Razumović J; Uzarević B; Petrovecki M; Marusić M; Radman I; Labar B
Leuk Lymphoma; 1992 May; 7(1-2):165-70. PubMed ID: 1472929
[TBL] [Abstract][Full Text] [Related]
4. Correlation between PCNA and AgNOR scores in non-Hodgkin's lymphomas using sequential staining technique.
Smith FG; Murray PG; Crocker J
J Clin Pathol; 1993 Jan; 46(1):28-31. PubMed ID: 8094401
[TBL] [Abstract][Full Text] [Related]
5. [The nucleolar organizer region in malignant non-Hodgkin's lymphoma].
Jakić-Razumović J; Labar B; Cör A; Radman I
Lijec Vjesn; 1992; 114(1-4):18-21. PubMed ID: 1343017
[TBL] [Abstract][Full Text] [Related]
6. Prognostic utility of silver stained nucleolar organiser region counting in non Hodgkin's lymphoma.
Iyer VK; Raina V; Dawar R
Indian J Cancer; 2000 Dec; 37(4):140-7. PubMed ID: 12018565
[TBL] [Abstract][Full Text] [Related]
7. A comparative assessment of proliferating cell nuclear antigen, c-myc p62, and nucleolar organizer region staining in non-Hodgkin's lymphomas: a histochemical and immunohistochemical study of 200 cases.
Korkolopoulou P; Patsouris E; Pangalis G; Tsenga A; Elemenoglou J; Thomas-Tsangli E; Spandidos D; Kittas C
Hum Pathol; 1993 Apr; 24(4):371-7. PubMed ID: 7684020
[TBL] [Abstract][Full Text] [Related]
8. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.
Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA
Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231
[TBL] [Abstract][Full Text] [Related]
9. Nucleoli and AgNORs in Hodgkin's disease.
Mamaev NN; Medvedeva NV; Shust VF; Markochev AB; Pasternak ND
Mol Pathol; 1997 Jun; 50(3):149-52. PubMed ID: 9292150
[TBL] [Abstract][Full Text] [Related]
10. Nucleolar organizer regions in lymphomas: a quantitative study.
Yekeler H; Ozercan MR; Yumbul AZ; Ağan M; Ozercan IH
Pathologica; 1993; 85(1097):353-60. PubMed ID: 8233651
[TBL] [Abstract][Full Text] [Related]
11. A comparison of nucleolar organizer region staining and Ki-67 immunostaining in non-Hodgkin's lymphoma.
Hall PA; Crocker J; Watts A; Stansfeld AG
Histopathology; 1988 Apr; 12(4):373-81. PubMed ID: 2453436
[TBL] [Abstract][Full Text] [Related]
12. Proliferating cell nuclear antigen (PCNA) and nucleolar organiser regions in Hodgkin's disease: correlation with morphology.
Freeman J; Kellock DB; Yu CC; Crocker J; Levison DA; Hall PA
J Clin Pathol; 1993 May; 46(5):446-9. PubMed ID: 8100573
[TBL] [Abstract][Full Text] [Related]
13. Correlation between DNA flow cytometric and nucleolar organizer region data in non-Hodgkin's lymphomas.
Crocker J; Macartney JC; Smith PJ
J Pathol; 1988 Feb; 154(2):151-6. PubMed ID: 3280766
[TBL] [Abstract][Full Text] [Related]
14. Morphometric analysis of AgNORs in the lymph node lesions.
Arora B; Jain R; Kumar S; Rekhi B; Arora H; Arora DR
Adv Clin Path; 2002 Apr; 6(2):95-9. PubMed ID: 19753731
[TBL] [Abstract][Full Text] [Related]
15. Effect of treatment on the prognostic value of S-phase fraction in non-Hodgkin's lymphoma.
Joensuu H; Ristamäki R; Söderström KO; Jalkanen S
J Clin Oncol; 1994 Oct; 12(10):2167-75. PubMed ID: 7931487
[TBL] [Abstract][Full Text] [Related]
16. Quantitative study of AgNOR in differential diagnosis between non-Hodgkin's lymphoma and reactive hyperplasia.
Gan X
Chin Med J (Engl); 1995 Feb; 108(2):132-7. PubMed ID: 7774388
[TBL] [Abstract][Full Text] [Related]
17. Prognostic implications of proliferating cell nuclear antigen (PCNA), AgNORs and P53 in non-Hodgkin's lymphomas.
Korkolopoulou P; Angelopoulou MK; Kontopidou F; Tsengas A; Patsouris E; Kittas C; Pangalis GA
Leuk Lymphoma; 1998 Aug; 30(5-6):625-36. PubMed ID: 9711925
[TBL] [Abstract][Full Text] [Related]
18. Nucleolar organizer region counts predict complete remission, remission duration, and survival in adult acute myelogenous leukemia patients.
Pich A; Chiusa L; Audisio E; Marmont F
J Clin Oncol; 1998 Apr; 16(4):1512-8. PubMed ID: 9552060
[TBL] [Abstract][Full Text] [Related]
19. Argyrophilic nucleolar organiser regions (AgNORs) count as indicator of post-surgical prognosis in feline mammary carcinomas.
Castagnaro M; Casalone C; Ru G; Nervi GC; Bozzetta E; Caramelli M
Res Vet Sci; 1998; 64(2):97-100. PubMed ID: 9625463
[TBL] [Abstract][Full Text] [Related]
20. Morphometric evaluation of nucleolar organiser regions in reactive and neoplastic lymph node lesions.
Arora B; Kumar S; Jain R
J Indian Med Assoc; 2006 Jan; 104(1):16-8, 24. PubMed ID: 16850861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
